CD248 (Ontuxizumab Biosimilar) antibody

Catalog No. ABIN7850143

The Humanized Chimeric anti-CD248 (Ontuxizumab Biosimilar) antibody is suitable to detect CD248 (Ontuxizumab Biosimilar) in samples from Human. It has been validated for FACS and ELISA.

Quick Overview for CD248 (Ontuxizumab Biosimilar) antibody (ABIN7850143)

Target: CD248 (Ontuxizumab Biosimilar)

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: Un-conjugated

Application: Flow Cytometry (FACS), ELISA

Product Details

Purpose: Anti-TEM1(ontuxizumab biosimilar) mAb

Isotype: E239D, IgG1, M241L, S286F

Application Details

Application Notes: ELISA 1:5000-10000, Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Lyophilized

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

Target Details

Target: CD248 (Ontuxizumab Biosimilar)

Alternative Name: ontuxizumab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:CD248, CD164L1
Synonyms Antibody:MORAb-004